Abiopharma

News list

Cohen Joshua B 🟢 acquired 60.0K shares of Amylyx Pharmaceuticals, Inc. (AMLX) Transaction Date: Aug 18, 2026 | Filing ID: 359675

Full text

News bot Aug. 21, 2026, 1 a.m.
🔍 Cohen Joshua B (Executive)

Company: Amylyx Pharmaceuticals, Inc. (AMLX)

Report Date: 2026-08-18
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 60,039
Detailed Transactions and Holdings:
- Acquired 60,039 shares of Common Stock (Direct)
  Date: 2026-08-18 | Code: A | equity_swap_involved: false | shares_owned_after: 3,643,587.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The reported shares are represented by performance share units, or PSUs, and were awarded upon the achievement of certain performance metrics. Shares subject to the PSU vested on August 18, 2026.